Free Trial

iShares U.S. Pharmaceuticals ETF (IHE) Short Interest Ratio & Short Volume

iShares U.S. Pharmaceuticals ETF logo
$99.49 +2.13 (+2.19%)
Closing price 04:10 PM Eastern
Extended Trading
$100.22 +0.73 (+0.73%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iShares U.S. Pharmaceuticals ETF Short Interest Overview

As of September 30, 2026, iShares U.S. Pharmaceuticals ETF (IHE) had a short interest of 259,952 shares sold short, representing 1.60% of the public float. This marks a -22.17% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.9, meaning it would take 1.9 days of the average trading volume of 166,790 shares to cover all short positions.

Current Short Interest
259,952 shares
Previous Short Interest
334,001 shares
Change Vs. Previous Month
-22.17%
Dollar Volume Sold Short
$26.13 million
Short Interest Ratio
1.9 Days to Cover
Last Record Date
September 30, 2026
Outstanding Shares
15,500,000 shares
Short Percent of Float
1.60%
Today's Trading Volume
432,223 shares
Average Trading Volume
166,790 shares
Today's Volume Vs. Average
259%
Short Selling iShares U.S. Pharmaceuticals ETF?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

IHE Short Interest Over Time

IHE Days to Cover Over Time

IHE Percentage of Float Shorted Over Time

iShares U.S. Pharmaceuticals ETF Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/2026259,952 shares $26.13 million -22.2%1.6%1.92 $100.52
9/15/2026334,001 shares $33.70 million -20.0%2.0%1.96 $100.89
8/31/2026417,249 shares $43.24 million +29.2%2.6%1.69 $103.64
8/14/2026322,900 shares $33.15 million -15.6%2.0%1.44 $102.66
7/31/2026382,457 shares $38.87 million +43.7%2.4%1.18 $101.62
7/15/2026266,083 shares $26.34 million -40.0%1.9%0.6 $98.99
6/30/2026443,214 shares $43.88 million -31.6%3.9%2.06 $99.01
6/15/2026647,772 shares $60.72 million +17.9%6.0%7.72 $93.73
5/29/2026549,437 shares $50.39 million -2.4%5.1%10.26 $91.72
5/15/2026562,677 shares $49.43 million +13.4%5.2%3.99 $87.84
4/30/2026496,088 shares $43.47 million -0.3%4.6%6.95 $87.63
4/15/2026497,736 shares $43.48 million -0.6%4.6%3.83 $87.36
3/31/2026500,669 shares $43.40 million +1.7%3.5%10.11 $86.68
3/13/2026492,124 shares $42.60 million -1.5%4.4%6.72 $86.56
2/27/2026499,665 shares $45.89 million +2.6%4.5%6.49 $91.84
2/13/2026487,136 shares $44.05 million -10.8%4.5%5.65 $90.42
1/30/2026546,267 shares $47.35 million +10.4%4.9%7.57 $86.68
1/15/2026494,738 shares $42.56 million -1.8%4.4%2.41 $86.02
12/31/2025503,809 shares $42.74 million +0.2%4.6%7.27 $84.83
12/15/2025503,020 shares $43.30 million +0.8%6.2%5.12 $86.08
11/28/2025499,297 shares $42.62 million +4.1%6.2%2.63 $85.36
11/14/2025479,563 shares $38.50 million +2.0%6.0%7.98 $80.28
10/31/2025470,087 shares $35.71 million -2.0%5.8%11.68 $75.97
10/15/2025479,800 shares $35.67 million +3.1%6.0%12.7 $74.34
9/30/2025465,500 shares $33.78 million +27.2%N/A12.4 $72.56
9/15/2025365,900 shares $25.69 million -1.2%N/A9.9 $70.21
8/31/2025370,200 shares $26.34 million -13.4%4.5%8.4 $71.16
8/15/2025427,600 shares $29.79 million +2.2%N/A8.9 $69.67
7/31/2025418,300 shares $27.50 million +17.6%5.1%6.9 $65.75
7/15/2025355,600 shares $23.57 million -1.8%N/A4.4 $66.28
6/30/2025362,100 shares $23.73 million -28.6%4.4%3.5 $65.54
6/15/2025507,100 shares $34.23 million +5.7%6.0%4.4 $67.50
5/31/2025479,900 shares $31.34 million +23.1%5.5%4.3 $65.30
5/15/2025390,000 shares $24.82 million -19.0%N/A3.4 $63.63
4/30/2025481,700 shares $32.82 million +43.1%N/A4.6 $68.14
4/15/2025336,700 shares $21.20 million +46.9%N/A3.6 $62.95
3/14/2025179,500 shares $12.44 million -19.2%N/A2.7 $69.32
2/14/2025184,000 shares $12.84 million +30.6%N/A2.7 $69.77
1/31/2025140,900 shares $9.78 million -19.6%N/A2.1 $69.44
1/15/2025175,200 shares $11.64 million -25.2%N/A2.9 $66.46
Elon pays this company. Every time. (Ad)

Every Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Starlink dish and AI satellite Elon launches. When Nvidia tried to buy the company, Elon reportedly fought the deal. Now his filing for 1,000,000 satellites could expand its revenue stream sharply. Dylan believes the stock could see significant movement starting October 24th.tc pixel

See which overlooked supplier Elon has quietly paid since 2012

IHE Short Interest - Frequently Asked Questions

Short interest is the volume of iShares U.S. Pharmaceuticals ETF shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 259,952 shares of IHE short. 1.60% of iShares U.S. Pharmaceuticals ETF's shares are currently sold short. Learn More on iShares U.S. Pharmaceuticals ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IHE shares currently have a short interest ratio of 1.9. Learn More on iShares U.S. Pharmaceuticals ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.60% of iShares U.S. Pharmaceuticals ETF's floating shares are currently sold short.

iShares U.S. Pharmaceuticals ETF saw a decrease in short interest in September. As of September 30th, there was short interest totaling 259,952 shares, a decrease of 22.2% from the previous total of 334,001 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.60% of iShares U.S. Pharmaceuticals ETF's shares are currently sold short. Here is how the short interest of companies compare to iShares U.S. Pharmaceuticals ETF: iShares U.S. Healthcare Providers ETF (1.99%), First Trust Health Care AlphaDEX Fund (0.03%), First Trust Nasdaq Pharmaceuticals ETF (0.04%), VanEck Pharmaceutical ETF (29.84%), Invesco S&P 500 Equal Weight Health Care ETF (3.21%), Direxion Daily S&P Biotech Bull 3X ETF (18.85%), Invesco Pharmaceuticals ETF (0.22%), VanEck Biotech ETF (1.58%), SPDR S&P Pharmaceuticals ETF (7.67%), Invesco Biotechnology & Genome ETF (0.29%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks.

Short selling IHE is an investing strategy that aims to generate trading profit from iShares U.S. Pharmaceuticals ETF as its price is falling. IHE shares are trading up $2.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares U.S. Pharmaceuticals ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IHE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IHE, twice per month. The most recent reporting period available is September, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like IHE:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NYSEARCA:IHE is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month.
From Our Partners